Enfusion, Inc.

Enfusion, Inc. (ENFN) priced its initial public offering on Oct 22, 2021 at $17.00 per share, raising $318.8M, and listed on NYSE. At the IPO price its market capitalization was about $1.92B. Morgan Stanley was lead-left underwriter, joined by Goldman Sachs. Goodwin Procter advised the company and Davis Polk advised the underwriters.

Enfusion, Inc. is a software-as-a-service provider for the investment management industry. Its solution unifies investment and operational workflows and data into a single dataset, helping investment managers make and execute decisions in real time.

Status

IPO

Ticker

ENFN

Exchange

NYSE

Priced

Oct 22, 2021

IPO price

$17.00

Raised

$318.8M

Market cap at IPO price

$1.92B

First filed

Sep 17, 2021

Underwriters

Morgan Stanley and Goldman Sachs

Company counsel

Goodwin Procter

Underwriters' counsel

Davis Polk

Sector

Technology

Country / state

IL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.